0001493152-25-004008.txt : 20250128 0001493152-25-004008.hdr.sgml : 20250128 20250128170033 ACCESSION NUMBER: 0001493152-25-004008 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250128 DATE AS OF CHANGE: 20250128 EFFECTIVENESS DATE: 20250128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dermata Therapeutics, Inc. CENTRAL INDEX KEY: 0001853816 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-536542 FILM NUMBER: 25565308 BUSINESS ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS RD., #322 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858)-223-0882 MAIL ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS RD., #322 CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0708 D LIVE 0001853816 Dermata Therapeutics, Inc. 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA CALIFORNIA 92130 (858)-223-0882 DELAWARE None None Corporation true 2021 Gerald Proehl 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Executive Officer Director Kyri K. Van Hoose 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Executive Officer Christopher J. Nardo 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Executive Officer Maria Bedoya Toro Munera 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Executive Officer David Hale 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Director Wendell Wierenga 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Director Andrew Sandler 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Director Brittany Bradrick 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Director Kathleen Scott 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Director Mary Fisher 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Director Steven J. Mento 3525 DEL MAR HEIGHTS RD., #322 San Diego CA CALIFORNIA 92130 Director Other Technology Decline to Disclose 06b false 2025-01-21 false true true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 PARK AVENUE 4TH FLOOR New York NY NEW YORK 10022 All States false 2550000 2550000 0 false 7 174751 0 Includes a cash fee equal to 7% of the aggregate gross proceeds raised from outside institutional investors and 3.5% of the aggregate gross proceeds raised from insider investors, a management fee of 1% and a non-accountable expense allowance of $25,000. 0 true Some of the proceeds may be used for working capital and general corporate purposes, including the payment of salaries and other fees to those listed in Item 3. false Dermata Therapeutics, Inc. /s/ Gerald Proehl Gerald Proehl Chief Executive Officer 2025-01-28